Corrigendum: Validation of the neuroconnective endophenotype questionnaire (NEQ): a new clinical tool for medicine and psychiatry resulting from the contribution of Ehlers–Danlos syndrome

• Antonio Bulbena,
• Antonio Bulbena,
• Silvia Rosado,
• Silvia Rosado,
• Marina Cabaleiro,
• Marina Cabaleiro,
• María Martinez,
• María Martinez,
• Carolina Baeza-Velasco,
• Carolina Baeza-Velasco,
• Carolina Baeza-Velasco,
• Luis-Miguel Martin,
• Santiago Batlle,
• Andrea Bulbena-Cabré

Affiliations

Antonio Bulbena

Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain

Antonio Bulbena

Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain

Silvia Rosado

Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain

Silvia Rosado

Doctorate Program in Psychiatry, Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain

Marina Cabaleiro

Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain

Marina Cabaleiro

Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain

María Martinez

Department of Psychiatry and Forensic Medicine, Universitat Autonoma Barcelona, Barcelona, Spain

María Martinez

Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain

Carolina Baeza-Velasco

Laboratoire de Psychopathologie et Processus de Santé, Université Paris Cité, Paris, France

Carolina Baeza-Velasco

Department of Emergency Psychiatry and Acute Care, CHU Montpellier, Montpellier, France

Carolina Baeza-Velasco

Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France

Luis-Miguel Martin

Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain

Santiago Batlle

Anxiety Unit, Hospital del Mar, Institute Neuropsychiatry and Addictions (INAD) CIBERSAM, Barcelona, Spain

Andrea Bulbena-Cabré

Icahn School of Medicine, Mount Sinai, New York, NY, United States